Fallah Haady, Fischer Gayle, Zagarella Samuel
Concord Repatriation General Hospital, Concord, New South Wales, Australia.
Australas J Dermatol. 2007 Nov;48(4):217-20. doi: 10.1111/j.1440-0960.2007.00389.x.
We report the successful treatment of five children with facial pyogenic granuloma using topical imiquimod 5% cream. In all cases, resolution of the lesions was achieved within 2-4 weeks. Local erythema and scaling, consistent with a typical imiquimod response, was the most commonly observed side effect. No systemic complications were observed in any of the patients. There has been no recurrence of any of the lesions to date. Small mildly erythematous or hypopigmented macules remain at this stage of follow up.
我们报告了使用5%咪喹莫特乳膏成功治疗5例面部化脓性肉芽肿患儿的情况。在所有病例中，皮损在2 - 4周内消退。局部红斑和脱屑是最常见的副作用，符合典型的咪喹莫特反应。所有患者均未观察到全身并发症。迄今为止，所有皮损均未复发。在随访的这个阶段仍有小的轻度红斑或色素减退斑。
